Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab175508-100μg
|
100μg |
10
|
$199.90
|
|
|
Ab175508-1mg
|
1mg |
4
|
$919.90
|
|
|
Ab175508-5mg
|
5mg |
1
|
$2,299.90
|
|
|
Ab175508-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$3,679.90
|
|
Purity>95% ( SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (Mc-MMAF)
| Product Name | Depatuxizumab mafodotin (anti-EGFR) - Primary antibody, specific to EGFR, Human IgG1, BINDING AGENT of Epidermal growth factor receptor erbB1 binding agent |
|---|---|
| Synonyms | Avian erythroblastic leukemia viral (v erb b) oncogene homolog antibody | Cell growth inhibiting protein 40 antibody | Cell proliferation inducing protein 61 antibody | EGF R antibody | EGFR antibody | EGFR_HUMAN antibody | Epidermal growth factor recepto |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | EGFR |
| Conjugation | Mc-MMAF |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Action Type | BINDING AGENT |
| Mechanism of action | BINDING AGENT of Epidermal growth factor receptor erbB1 binding agent |
| Product Description |
Depatuxizumab mafodotin (anti-EGFR) is an antibody-drug conjugate consisting of an EGFR IGg1 monoclonal antibody conjugated to the tubulin inhibitor monomethyl auristatin F via a stable maleimidocaproyl link. Depatuxizumab mafodotin (anti-EGFR) is used in the treatment of recurrent EGFR-amplified Glioblastoma (GBM). |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 26.7 kDa (Light Chain) & 51.5 kDa (Heavy Chain), under reducing conditions; 188.1 kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 1585973-65-4 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Depatuxizumab mafodotin (anti-EGFR) (Ab175508) - Flow Cytometry
Flow Cytometry analysis of A431 cells labelling EGFR (red) with Depatuxizumab mafodotin (anti-EGFR) (Ab175508). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Depatuxizumab mafodotin (anti-EGFR) (Ab175508) - ELISA
Immobilized EGFR-chis at 2 μg/mL can bind Depatuxizumab mafodotin (anti-EGFR) (Ab175508) with the EC₅₀ of 19.05 ng/mL.
Depatuxizumab mafodotin (anti-EGFR) (Ab175508) - Flow Cytometry
Flow Cytometry analysis of Hela cells labelling EGFR (red) with Depatuxizumab mafodotin (anti-EGFR) (Ab175508). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Depatuxizumab mafodotin (anti-EGFR) (Ab175508) - Flow Cytometry
Flow Cytometry analysis of A549 cells labelling EGFR (red) with Depatuxizumab mafodotin (anti-EGFR) (Ab175508). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Depatuxizumab mafodotin (anti-EGFR) (Ab175508) - SEC
The purity of Depatuxizumab mafodotin (anti-EGFR) (Ab175508) is more than 95% verified by HPLC.
Depatuxizumab mafodotin (anti-EGFR) (Ab175508) - ELISA
Immobilized Recombinant Human EGFR protein (rp176273) at 1.0 μg/mL can bind Depatuxizumab mafodotin (anti-EGFR) (Ab175508) with the EC50 of 28.96 ng/mL.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jan 26, 2024 | Ab175508 | |
| Certificate of Analysis | Jan 26, 2024 | Ab175508 | |
| Certificate of Analysis | Jan 26, 2024 | Ab175508 |
Starting at $109.90
Starting at $49.90
Starting at $69.90
Starting at $54.90
Starting at $59.90
Starting at $59.90
Starting at $69.90
Starting at $49.90
Starting at $69.90
Starting at $64.90
Starting at $59.90
Starting at $59.90
Starting at $89.90
Starting at $59.90